What is the 13F Pro Quality Score for AZN?

13F Pro ranks ASTRAZENECA PLC (AZN) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View AZN's current score at https://13fpro.ai/company/AZN (free sign-up required for the full ranking).

Where does 13F Pro source AZN data?

All ASTRAZENECA PLC fundamentals and ownership data come directly from SEC EDGAR. ASTRAZENECA PLC files with the SEC under CIK 901832. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is AZN in?

ASTRAZENECA PLC (AZN) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is AZN research updated on 13F Pro?

AZN's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ASTRAZENECA PLC(AZN)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSEmega

Institutional-grade research for retail investors

SEC EDGAR: CIK 901832 AZN stock profile & AI dashboard →

InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro Quality Score

70.5/100

Rank #215 of 2,961 stocksTOP 10%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why AZN Scores 71/100

exact factor attribution · 2026-09-11

AZN's composite is driven by revenue growth and scale, held back by free cash flow and earnings quality. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+7.3 pts

87th pct

Scale

+7.0 pts

97th pct

Profitability

+2.9 pts

69th pct

Capital efficiency

+2.3 pts

73th pct

Shareholder dilution

+2.1 pts

93th pct

Earnings growth

+2.1 pts

91th pct

Institutional flow

+1.9 pts

88th pct

Earnings quality

-2.0 pts

30th pct

Free cash flow

-3.0 pts

30th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

AZN Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for ASTRAZENECA PLC (AZN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AZN at 70.5/100 on a 32-signal composite quality model, placing it at rank #215 of 2,961 stocks — the top 10% of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), ASTRAZENECA PLC reports quarterly revenue of $58.7B, net income of $10.2B. Top institutional holders of AZN by reported 13-F value include Evelyn Partners Group Ltd, INVESTOR AB, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. AZN trades on the NYSE exchange and files with the SEC under CIK 901832. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AZN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ASTRAZENECA PLC directly from SEC EDGAR. ASTRAZENECA PLC's 13F Pro composite quality score has ranged between 43 and 71 since 2026, currently 70.5 — an improving long-term trajectory across 47 quarterly and live scoring snapshots.

Revenue

FY 2025

$58.7B

Net Income

FY 2025

$10.2B

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+8.6% YoY

$58.74BFY 2025

FY22 $44.35BFY23 $45.81BFY24 $54.07BFY25 $58.74B

Total Assets

+9.6% YoY

$114.07BFY 2025

FY22 $96.48BFY23 $101.12BFY24 $104.03BFY25 $114.07B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$58.74B +8.6%	$54.07B +18.0%	$45.81B +3.3%	$44.35B +18.5%	$37.42B +40.6%	$26.62B
Total Assets	$114.07B +9.6%	$104.03B +2.9%	$101.12B +4.8%	$96.48B -8.4%	$105.36B +57.9%	$66.73B

Get alerted when AZN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ASTRAZENECA PLC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of AZN

Evelyn Partners Group Ltd
$41.5B2,237,205 sh
INVESTOR AB
$9.8B51,587,810 sh
VANGUARD CAPITAL MANAGEMENT LLC
$8.5B45,386,190 sh
Capital International Investors
$6.5B34,576,070 sh
NORGES BANK
$6.3B33,864,172 sh
Capital World Investors
$5.6B30,075,134 sh
FMR LLC
$5.4B28,895,264 sh
WELLINGTON MANAGEMENT GROUP LLP
$5.4B28,537,243 sh
Legal & General Group Plc
$4.8B25,750,245 sh
JPMORGAN CHASE & CO
$3.7B19,204,823 sh

Fund	Value	Shares
Evelyn Partners Group Ltd	$41.5B	2,237,205
INVESTOR AB	$9.8B	51,587,810
VANGUARD CAPITAL MANAGEMENT LLC	$8.5B	45,386,190
Capital International Investors	$6.5B	34,576,070
NORGES BANK	$6.3B	33,864,172
Capital World Investors	$5.6B	30,075,134
FMR LLC	$5.4B	28,895,264
WELLINGTON MANAGEMENT GROUP LLP	$5.4B	28,537,243
Legal & General Group Plc	$4.8B	25,750,245
JPMORGAN CHASE & CO	$3.7B	19,204,823

Companies Similar to AZN

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

NVO

NOVO NORDISK A S

AI score

Very similar · 14 shared holders

Capital International Investors Capital World Investors FARALLON CAPITAL MANAGEMENT LLC

GSK

GSK plc

AI score

Shared smart-money ownership · 3 shared holders

PRIMECAP MANAGEMENT CO/CA/CRAWFORD INVESTMENT COUNSEL INC KORNITZER CAPITAL MANAGEMENT INC /KS

UNILEVER PLC

AI score

Shared smart-money ownership · 13 shared holders

Clearbridge Investments, LLC Saturna Capital CORP Lansforsakringar Fondforvaltning AB (publ)

UNH

UNITEDHEALTH GROUP INC

AI score

Shared smart-money ownership · 26 shared holders

Capital World Investors Capital International Investors Sanders Capital, LLC

CVS

CVS HEALTH Corp

AI score

Shared smart-money ownership · 26 shared holders

Capital World Investors Capital International Investors Clearbridge Investments, LLC

SNN

SMITH & NEPHEW PLC

AI score

Similar quality profile · 4 shared holders

CAUSEWAY CAPITAL MANAGEMENT LLC KORNITZER CAPITAL MANAGEMENT INC /KS Boston Partners

ABT

ABBOTT LABORATORIES

AI score

Shared smart-money ownership · 28 shared holders

Capital International Investors Capital Research Global Investors Rathbones Group PLC

MDT

Medtronic plc

AI score

Shared smart-money ownership · 25 shared holders

Capital Research Global Investors Capital World Investors M&G Plc

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put AZN on your watchlist

Track score changes the day ASTRAZENECA PLC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is AZN a good stock to buy?

13F Pro's AI-powered analysis of ASTRAZENECA PLC (AZN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AZN are available on the AZN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. AZN is classified as a mega company.

Which hedge funds own AZN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AZN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ASTRAZENECA PLC's investment landscape.